Journal article
Double blind placebo controlled trial of short term transdermal scopolamine on heart rate variability in patients with chronic heart failure.
Abstract
OBJECTIVE: To test the hypothesis that short term application of transdermal scopolamine increases heart rate variability (HRV) and restores sympathovagal balance in patients with stable congestive heart failure (CHF).
DESIGN: A double blind placebo controlled crossover study.
Authors
Venkatesh G; Fallen EL; Kamath MV; Connolly S; Yusuf S
Journal
Heart, Vol. 76, No. 2,
Publisher
BMJ
Publication Date
8 1996
DOI
10.1136/hrt.76.2.137
ISSN
1355-6037